CD19-targeted CAR T cells in refractory antisynthetase syndrome

Müller F, Böltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, Taubmann J, Kretschmann S, Rösler W, Manger B, Wacker J, Mougiakakos D, Jabari S, Schröder R, Uder M, Roemer F, Krönke G, Mackensen A, Schett G (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Lancet Elsevier: Lancet

Book Volume: 401

Pages Range: 815-818

Journal Issue: 10379

DOI: 10.1016/S0140-6736(23)00023-5

Authors with CRIS profile

Fabian Müller Department of Medicine 5 – Haematology and Oncology Sebastian Böltz Department of Medicine 5 – Haematology and Oncology Johannes Knitza Department of Medicine 3 – Rheumatology and Immunology Simon Völkl Department of Medicine 5 – Haematology and Oncology Soraya Kharboutli Medizinische Fakultät Hannah Reimann Department of Medicine 5 – Haematology and Oncology Jule Taubmann Department of Medicine 3 – Rheumatology and Immunology Wolf Rösler Department of Medicine 5 – Haematology and Oncology Bernhard Manger Professur für Rheumatologie und Klinische Immunologie Samir Jabari Institute of Neuropathology Rolf Schröder Professur für Neuropathologie Michael Uder Lehrstuhl für Diagnostische Radiologie Frank Roemer Institute of Radiology Gerhard Krönke Medizinische Fakultät Andreas Mackensen Lehrstuhl für Innere Medizin V Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Otto-von-Guericke-Universität Magdeburg DE Germany (DE)

How to cite

APA:

Müller, F., Böltz, S., Knitza, J., Aigner, M., Völkl, S., Kharboutli, S.,... Schett, G. (2023). CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet, 401(10379), 815-818. https://doi.org/10.1016/S0140-6736(23)00023-5

MLA:

Müller, Fabian, et al. "CD19-targeted CAR T cells in refractory antisynthetase syndrome." Lancet 401.10379 (2023): 815-818.

BibTeX: Download